series-a
Stage
2
Investors
About
sustained-release therapeutics for sight-threatening ocular diseases
Explore Re-Vana Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
sustained-release therapeutics for sight-threatening ocular diseases
Funding rounds, investor list, and risk signals — unlock with a subscription.